Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1471-1474
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Effect of Mifepristone (RU 486) on Plasma Cortisol in Alzheimer’s DiseaseNeurochemical Research, 2006
- Progesterone Receptor Ligand Binding Pocket Flexibility: Crystal Structures of the Norethindrone and Mometasone Furoate ComplexesJournal of Medicinal Chemistry, 2004
- The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding DomainJournal of Biological Chemistry, 2003
- Antiglucocorticoid drugs in the treatment of depressionExpert Opinion on Investigational Drugs, 2001
- Successful Long-Term Treatment of Refractory Cushing's Disease with High-Dose Mifepristone (RU 486)The Journal of Clinical Endocrinology & Metabolism, 2001
- Nuclear receptors, coactivators and chromatin: new approaches, new insightsTrends in Endocrinology & Metabolism, 2001
- Syntheses and GABA receptor binding properties of 4-amino-1-, 2-, and 3-hydroxybutylphosphinic acidsTetrahedron, 1999
- RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient β-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob miceInternational Journal of Obesity, 1997
- Glucocorticoid receptor function in health and diseaseCurrent Opinion in Endocrinology, Diabetes and Obesity, 1997
- Treatment of Glaucoma with 3α,5β-Tetrahydrocortisol: A New Therapeutic ModalityJournal of Ocular Pharmacology and Therapeutics, 1994